when can i get retatrutide 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in RETATRUTIDE (RETA) – Research Peptide

Units depend on concentration, not just dose: the same 2mg dose is 40 units at 5mg/mL but only 20 units at 10mg/mL

A licensed U.S

Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges

Mistake 4: Measuring water volume incorrectly Adding 0.8 mL instead of 1.0 mL changes your concentration from 10 mg/mL to 12.5 mg/mL

Arm Use the fatty area on the back of your arm, between your shoulder and elbow

Take our free assessment quiz today to see if you qualify for our prescription weight loss medications and embark on a path toward a healthier, more vibrant you with TrimRx